275 related articles for article (PubMed ID: 33206686)
1. Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
Grohová A; Dáňová K; Adkins I; Šumník Z; Petruželková L; Obermannová B; Koloušková S; Špíšek R; Palová-Jelínková L
PLoS One; 2020; 15(11):e0242092. PubMed ID: 33206686
[TBL] [Abstract][Full Text] [Related]
2. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets.
Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D
Front Immunol; 2019; 10():475. PubMed ID: 30936876
[TBL] [Abstract][Full Text] [Related]
3. The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis.
Wang Y; Tian J; Wang S
Semin Arthritis Rheum; 2016 Feb; 45(4):490-5. PubMed ID: 26272193
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
7. 1α, 25 Dihydroxyvitamin D (1,25(OH)
Fleet JC; Burcham GN; Calvert RD; Elzey BD; Ratliff TL
J Steroid Biochem Mol Biol; 2020 Apr; 198():105557. PubMed ID: 31783150
[TBL] [Abstract][Full Text] [Related]
8. Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice.
Wang Y; Tian J; Tang X; Rui K; Tian X; Ma J; Ma B; Xu H; Lu L; Wang S
Oncotarget; 2016 Mar; 7(13):15356-68. PubMed ID: 26885611
[TBL] [Abstract][Full Text] [Related]
9. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.
Xing YF; Cai JR; Qin JJ; Zhou WY; Li CM; Li X
Front Immunol; 2020; 11():577253. PubMed ID: 33584644
[TBL] [Abstract][Full Text] [Related]
10. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients.
Whitfield-Larry F; Felton J; Buse J; Su MA
Clin Immunol; 2014 Jul; 153(1):156-64. PubMed ID: 24769355
[TBL] [Abstract][Full Text] [Related]
12. Myeloid derived suppressor cells and autoimmunity.
Boros P; Ochando J; Zeher M
Hum Immunol; 2016 Aug; 77(8):631-636. PubMed ID: 27240453
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes.
Kikodze N; Pantsulaia I; Rekhviashvili Kh; Iobadze M; Dzhakhutashvili N; Pantsulaia N; Kukuladze N; Bikashvili N; Metreveli D; Chikovani T
Georgian Med News; 2013 Sep; (222):29-35. PubMed ID: 24099812
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.
Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C
Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway.
Pang B; Zhen Y; Hu C; Ma Z; Lin S; Yi H
Clin Sci (Lond); 2020 Aug; 134(16):2209-2222. PubMed ID: 32808653
[TBL] [Abstract][Full Text] [Related]
16. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability.
Zhao Y; Shao Q; Zhu H; Xu H; Long W; Yu B; Zhou L; Xu H; Wu Y; Su Z
Cancer Sci; 2018 Sep; 109(9):2677-2686. PubMed ID: 29959821
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.
Köstlin N; Schoetensack C; Schwarz J; Spring B; Marmé A; Goelz R; Brodbeck G; Poets CF; Gille C
Front Immunol; 2018; 9():1098. PubMed ID: 29868036
[TBL] [Abstract][Full Text] [Related]
19. Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery.
Agrati C; Tumino N; Bordoni V; Pinnetti C; Sabatini A; Amendola A; Abbate I; Lorenzini P; Mondi A; Casetti R; Cimini E; Grassi G; Antinori A; Sacchi A
Front Immunol; 2019; 10():1886. PubMed ID: 31440256
[TBL] [Abstract][Full Text] [Related]
20. Presence of Infected Gr-1
Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
Front Immunol; 2018; 9():2317. PubMed ID: 30386330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
